MUC5AC and adrenomyeloneuropathy: Actually, there is no clear evidence on the prevalence and clinical presentation of AMN among patients with inflammatory bowel disease (IBD), but a well-documented higher risk of gastrointestinal malignant transformation [8] as well as growing evidence of appendiceal involvement [9,10] warrants particular consideration when dealing with mucin-containing appendix masses in these patients.